Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8268604rdf:typepubmed:Citationlld:pubmed
pubmed-article:8268604lifeskim:mentionsumls-concept:C0019004lld:lifeskim
pubmed-article:8268604lifeskim:mentionsumls-concept:C0041004lld:lifeskim
pubmed-article:8268604lifeskim:mentionsumls-concept:C0040018lld:lifeskim
pubmed-article:8268604lifeskim:mentionsumls-concept:C1522492lld:lifeskim
pubmed-article:8268604lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:8268604pubmed:issue3lld:pubmed
pubmed-article:8268604pubmed:dateCreated1994-1-31lld:pubmed
pubmed-article:8268604pubmed:abstractTextEffect of blood-air contact in the venous line air-trap chamber on blood clotting was studied. Fourteen chronic hemodialysis patients (six men, eight women; mean age, 49 years) with elevation of thrombin-antithrombin III were studied. To prevent blood-air contact, triglyceride (NOF-005) was floated over the blood in the chamber. Control hemodialysis was performed for 4 weeks and hemodialysis using NOF-005 followed for the next 4 weeks. Clot formation in the circuit was examined after each hemodialysis and clotting factors including thrombin-antithrombin III, FXII Antigen, vWF Antigen, PF4 and beta-thromboglobulin were measured before and after the last hemodialysis of each control and NOF-005 hemodialysis. Clotting in the chamber was improved when NOF-005 was used. Thrombin-antithrombin III increase during hemodialysis was suppressed to about 30% of control values by using NOF-005. blood-air contact seems to promote thrombin generation and accelerate clot formation.lld:pubmed
pubmed-article:8268604pubmed:languageenglld:pubmed
pubmed-article:8268604pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8268604pubmed:citationSubsetIMlld:pubmed
pubmed-article:8268604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8268604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8268604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8268604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8268604pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8268604pubmed:statusMEDLINElld:pubmed
pubmed-article:8268604pubmed:issn1058-2916lld:pubmed
pubmed-article:8268604pubmed:authorpubmed-author:SatoTTlld:pubmed
pubmed-article:8268604pubmed:authorpubmed-author:FukuiHHlld:pubmed
pubmed-article:8268604pubmed:authorpubmed-author:KasamaTTlld:pubmed
pubmed-article:8268604pubmed:authorpubmed-author:NoguchiYYlld:pubmed
pubmed-article:8268604pubmed:authorpubmed-author:MatsushitaKKlld:pubmed
pubmed-article:8268604pubmed:authorpubmed-author:SoejimaHHlld:pubmed
pubmed-article:8268604pubmed:authorpubmed-author:KitamotoYYlld:pubmed
pubmed-article:8268604pubmed:issnTypePrintlld:pubmed
pubmed-article:8268604pubmed:volume39lld:pubmed
pubmed-article:8268604pubmed:ownerNLMlld:pubmed
pubmed-article:8268604pubmed:authorsCompleteYlld:pubmed
pubmed-article:8268604pubmed:paginationM581-3lld:pubmed
pubmed-article:8268604pubmed:dateRevised2006-5-23lld:pubmed
pubmed-article:8268604pubmed:meshHeadingpubmed-meshheading:8268604-...lld:pubmed
pubmed-article:8268604pubmed:meshHeadingpubmed-meshheading:8268604-...lld:pubmed
pubmed-article:8268604pubmed:meshHeadingpubmed-meshheading:8268604-...lld:pubmed
pubmed-article:8268604pubmed:meshHeadingpubmed-meshheading:8268604-...lld:pubmed
pubmed-article:8268604pubmed:meshHeadingpubmed-meshheading:8268604-...lld:pubmed
pubmed-article:8268604pubmed:meshHeadingpubmed-meshheading:8268604-...lld:pubmed
pubmed-article:8268604pubmed:meshHeadingpubmed-meshheading:8268604-...lld:pubmed
pubmed-article:8268604pubmed:meshHeadingpubmed-meshheading:8268604-...lld:pubmed
pubmed-article:8268604pubmed:meshHeadingpubmed-meshheading:8268604-...lld:pubmed
pubmed-article:8268604pubmed:meshHeadingpubmed-meshheading:8268604-...lld:pubmed
pubmed-article:8268604pubmed:meshHeadingpubmed-meshheading:8268604-...lld:pubmed
pubmed-article:8268604pubmed:meshHeadingpubmed-meshheading:8268604-...lld:pubmed
pubmed-article:8268604pubmed:meshHeadingpubmed-meshheading:8268604-...lld:pubmed
pubmed-article:8268604pubmed:articleTitleSuppression of thrombin formation during hemodialysis with triglyceride.lld:pubmed
pubmed-article:8268604pubmed:affiliationThird Department of Internal Medicine, Kumamoto University School of Medicine, Japan.lld:pubmed
pubmed-article:8268604pubmed:publicationTypeJournal Articlelld:pubmed